Literature DB >> 11156575

Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.

J Simon1, P Vigne, K M Eklund, A D Michel, A M Carruthers, P P Humphrey, C Frelin, E A Barnard.   

Abstract

1. A P2Y (nucleotide) receptor activity in a clonal population (B10) of rat brain capillary endothelial cells is coupled to inhibition of adenylyl cyclase and has functional similarities to the P2Y(T) (previously designated 'P2T') receptor for ADP of blood platelets. However, the only P2Y receptor which was detectable in a previous study of B10 cells by mRNA analysis was the P2Y(1) receptor, which elsewhere shows no transduction via cyclic nucleotides. We have sought here to clarify these issues. 2. The inhibition of forskolin-stimulated adenylyl cyclase induced by purified nucleotides was measured on B10 cells. The EC(50) value for 2-methylthioADP (2-MeSADP) was 2.2 nM and, surprisingly, 2-MeSATP was an almost equally strong agonist (EC(50)=3.5 nM). ATP and 2-ClATP were weak partial agonists (EC(50)=26 microM and 10 microM respectively) and under appropriate conditions could antagonise the activity on 2-MeSADP. 3. A known selective antagonist of the platelet P2Y(T) receptor, 2-propylthioadenosine-5'-(beta,gamma)-difluoromethylene) triphosphonate (AR-C 66096), was a competitive antagonist of this B10 cell receptor, with pK(B)=7.6. That ligand is inactive at the P2Y(1) receptor in the same cells. Conversely, the competitive P2Y(1) receptor antagonists, the 3', 5'- and 2', 5'-adenosine bis-monophosphates, are, instead, weak agonists at the adenylyl cyclase-inhibitory receptor. 4. The inhibition of adenylyl cyclase by 2-MeSADP was completely abolished by pertussis toxin. 5. In summary, these brain endothelial cells possess a P2Y(T)-type receptor in addition to the P2Y(1) receptor. The two have similarities in agonist profiles but are clearly distinguishable by antagonists and by their second messenger activations. The possible relationships between the B10 and platelet P2Y(T) receptors are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156575      PMCID: PMC1572558          DOI: 10.1038/sj.bjp.0703816

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Agonist action of adenosine triphosphates at the human P2Y1 receptor.

Authors:  R K Palmer; J L Boyer; J B Schachter; R A Nicholas; T K Harden
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

3.  Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

Authors:  J E Fabre; M Nguyen; A Latour; J A Keifer; L P Audoly; T M Coffman; B H Koller
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

Review 4.  Receptors for ADP on human blood platelets.

Authors:  S M Hourani; D A Hall
Journal:  Trends Pharmacol Sci       Date:  1994-04       Impact factor: 14.819

5.  Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.

Authors:  J Jin; J L Daniel; S P Kunapuli
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.

Authors:  J Geiger; P Hönig-Liedl; P Schanzenbächer; U Walter
Journal:  Eur J Pharmacol       Date:  1998-06-19       Impact factor: 4.432

7.  Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.

Authors:  J L Boyer; E R Lazarowski; X H Chen; T K Harden
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

8.  P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.

Authors:  M S Fagura; I A Dainty; G D McKay; I P Kirk; R G Humphries; M J Robertson; I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1998-05       Impact factor: 8.739

9.  Cloning and functional expression of a brain G-protein-coupled ATP receptor.

Authors:  T E Webb; J Simon; B J Krishek; A N Bateson; T G Smart; B F King; G Burnstock; E A Barnard
Journal:  FEBS Lett       Date:  1993-06-14       Impact factor: 4.124

10.  Evidence for the existence of two different ADP-binding sites on rat platelets.

Authors:  P Savi; M C Laplace; J M Herbert
Journal:  Thromb Res       Date:  1994-10-15       Impact factor: 3.944

View more
  10 in total

1.  Inhibition of adenylyl cyclase by neuronal P2Y receptors.

Authors:  Ursula Unterberger; Eugenia Moskvina; Thomas Scholze; Michael Freissmuth; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.

Authors:  Gary L Waldo; James Corbitt; José L Boyer; Gnana Ravi; Hak Sung Kim; Xiao-Duo Ji; James Lacy; Kenneth A Jacobson; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

Review 3.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 4.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

5.  Expression of the P2Y1 nucleotide receptor in chick muscle: its functional role in the regulation of acetylcholinesterase and acetylcholine receptor.

Authors:  R C Choi; M L Man; K K Ling; N Y Ip; J Simon; E A Barnard; K W Tsim
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Regulating quantal size of neurotransmitter release through a GPCR voltage sensor.

Authors:  Quanfeng Zhang; Bing Liu; Yinglin Li; Lili Yin; Muhammad Younus; Xiaohan Jiang; Zhaohan Lin; Xiaoxuan Sun; Rong Huang; Bin Liu; Qihui Wu; Feipeng Zhu; Zhuan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-12       Impact factor: 11.205

7.  Activation of P2Y1 nucleotide receptors induces inhibition of the M-type K+ current in rat hippocampal pyramidal neurons.

Authors:  Alexander K Filippov; Roy C Y Choi; Joseph Simon; Eric A Barnard; David A Brown
Journal:  J Neurosci       Date:  2006-09-06       Impact factor: 6.167

8.  ATP induces synaptic gene expressions in cortical neurons: transduction and transcription control via P2Y1 receptors.

Authors:  Nina L Siow; Roy C Y Choi; Heidi Q Xie; Ling W Kong; Glanice K Y Chu; Gallant K L Chan; Joseph Simon; Eric A Barnard; Karl W K Tsim
Journal:  Mol Pharmacol       Date:  2010-09-16       Impact factor: 4.436

9.  Attenuation of the P2Y receptor-mediated control of neuronal Ca2+ channels in PC12 cells by antithrombotic drugs.

Authors:  Helmut Kubista; Stefan G Lechner; Angelika M Wolf; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.

Authors:  P Swiatkowski; M Murugan; U B Eyo; Y Wang; S Rangaraju; S B Oh; L-J Wu
Journal:  Neuroscience       Date:  2016-01-12       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.